Molecular analysis of encapsulated papillary carcinoma of the breast with and without invasion

Hum Pathol. 2021 May:111:67-74. doi: 10.1016/j.humpath.2021.02.005. Epub 2021 Mar 3.

Abstract

Encapsulated papillary carcinomas (EPCs) of the breast are a unique variant of papillary carcinoma confined to a cystic space with absent or attenuated myoepithelial cell layer. Although staged as an in situ lesion, it can be associated with invasive ductal carcinoma (IDC). We sought to compare the genomic characteristics of pure EPC and EPC with associated invasive carcinoma (EPCi) at the genomic level. All cases of EPCi harbored recurrent hotspot mutations in PIK3CA. PIK3CA, KMT2A, and CREBBP deleterious somatic events were found across both tumor groups, irrespective of invasion status. At the whole transcriptomic level, EPCi cases displayed remarkably similar mRNA profiles when compared to EPC. When EPCi cases were compared with their corresponding IDC, despite significant overlap, we identified differential gene expression in 39 genes with enrichment of multiple pathways including extracellular matrix regulation, cell adhesion, and collagen fibril organization. Despite morphologic, genotypic, and transcriptomic overlap between pure EPC and EPCi, the latter tumors are likely advanced lesions with PIK3CA activating mutations and enrichment of stromal-related genes implicated in the switch to IDC.

Keywords: Encapsulated papillary carcinoma; Invasive ductal carcinoma; PIK3CA; RNA sequencing; Whole transcriptome.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / genetics
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / pathology*
  • Carcinoma, Ductal, Breast / genetics*
  • Carcinoma, Ductal, Breast / pathology*
  • Carcinoma, Papillary / genetics*
  • Carcinoma, Papillary / pathology*
  • Class I Phosphatidylinositol 3-Kinases / genetics
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mutation
  • Retrospective Studies

Substances

  • Biomarkers, Tumor
  • Class I Phosphatidylinositol 3-Kinases
  • PIK3CA protein, human